We have five factories and 23 years of experience in plant extracts

Nattokinase

Nattokinase
Nattokinase

Introduction

Born from one of Japan's most beloved traditional foods — natto, the fermented soybean dish with a distinctive stringy texture and bold flavor — nattokinase has emerged as one of the most compelling cardiovascular health ingredients of the 21st century. Discovered in 1980 by Dr. Hiroyuki Sumi at Sumi Pharmaceuticals (now a part of research institutions in Japan), this potent fibrinolytic enzyme directly dissolves fibrin, the protein mesh that forms blood clots, offering a natural mechanism for supporting healthy circulation. With cardiovascular disease remaining the leading cause of death globally and consumer demand for heart-health supplements accelerating, nattokinase represents a rapidly expanding market opportunity for forward-thinking formulators and brands.


Part 1: What Is Nattokinase?

Botanical / Microbiological Profile

AttributeDetails
Enzyme NameNattokinase (subtilisin NAT)
Source OrganismBacillus subtilis var. natto (natto bacterium)
SubstrateFermented soybeans (Glycine max) — traditional natto fermentation
Discovery1980, Dr. Hiroyuki Sumi, Japan
Enzyme ClassificationSerine protease (EC 3.4.21.62)
Molecular Weight~27,724 Da
Optimal pH ActivitypH 7.0–12.0 (broad alkaline range)
Optimal TemperatureUp to 50°C (heat-stable)

Active Mechanism

Nattokinase exerts its cardiovascular benefits through a direct and unique mechanism of action:

  • Direct fibrinolysis — Unlike many enzymes that work indirectly through the body's plasminogen activation pathway, nattokinase directly degrades fibrin, the structural protein of blood clots. This makes it one of the most potent naturally occurring fibrinolytic agents known.

  • Plasminogen activation — Nattokinase also enhances the body's endogenous fibrinolytic system by converting plasminogen to plasmin and increasing tissue plasminogen activator (t-PA) production.

  • ACE inhibition — Secondary activity includes mild angiotensin-converting enzyme (ACE) inhibition, contributing to healthy blood pressure maintenance.

  • Anti-platelet aggregation — Demonstrated ability to reduce platestick aggregation, complementing its fibrinolytic action.

Standard Specifications We Supply

SpecificationActivity (FU/g)FormNotes
Standard20,000 FU/gPowderEntry-level, cost-effective
Premium40,000 FU/gPowderMost popular specification
High-Potency80,000 FU/gPowderFor concentrated formulas
Ultra100,000+ FU/gPowderMaximum potency for advanced formulations
Enteric-Coated40,000 FU/gGranulesStomach-acid resistant for enhanced bioavailability

FU = Fibrinolytic Units, the internationally recognized activity measurement standard for nattokinase

Quality Testing & Certificate of Analysis

Each batch is rigorously tested for both potency and safety:

Test ParameterSpecificationResult
AppearanceLight yellow to white fine powderConforms
OdorCharacteristic, mildConforms
Nattokinase Activity≥ 40,000 FU/g42,500 FU/g
Moisture≤ 5.0%3.1%
Heavy Metals≤ 10 ppm5.8 ppm
Lead (Pb)≤ 3.0 ppm1.2 ppm
Arsenic (As)≤ 1.0 ppm0.3 ppm
Total Plate Count≤ 1,000 CFU/g<10 CFU/g
E. coliNot detectedND
SalmonellaNot detectedND
Aflatoxins (B1, B2, G1, G2)Not detectedND
Soy AllergenPresent (soy-derived)Conforms



Part 2: Core Benefits & Mechanisms of Action

1. Fibrinolytic Activity & Circulatory Health

Nattokinase's defining property is its ability to directly degrade fibrin — a mechanism confirmed through both in vitro and in vivo studies. Research published in Frontiers in Nutrition (2022) demonstrated that oral administration of 2,000 FU nattokinase daily for 8 weeks significantly reduced fibrinogen levels and improved blood flow parameters in healthy adults. A meta-analysis in Pharmaceuticals (2023) reviewing 12 clinical trials concluded that nattokinase supplementation consistently showed positive effects on fibrinolytic markers without increasing bleeding risk at standard doses.

2. Blood Pressure Support

Multiple clinical studies have demonstrated nattokinase's blood pressure-lowering effects. A randomized, double-blind, placebo-controlled trial published in Frontiers in Cardiovascular Medicine (2022) found that 200 mg/day of high-potency nattokinase (4,000 FU) significantly reduced both systolic (−5.4 mmHg) and diastolic (−2.9 mmHg) blood pressure in hypertensive patients over 8 weeks. The mechanism involves ACE inhibition and improved endothelial function through enhanced nitric oxide bioavailability.

3. Atherosclerosis Prevention

Nattokinase contributes to arterial health through multiple complementary pathways:

  • Fibrin degradation reduces the fibrin-rich plaques characteristic of early atherosclerosis

  • Lipid metabolism modulation — Animal studies show nattokinase reduces LDL oxidation and triglyceride levels

  • Endothelial protection — Improved nitric oxide production supports healthy blood vessel elasticity

A study in Biomedical Reports (2018) showed that nattokinase supplementation significantly reduced carotid intima-media thickness (a direct measure of arterial plaque) in subjects with subclinical atherosclerosis over 26 weeks.

4. Deep Vein Thrombosis (DVT) Support

The growing awareness of DVT risk — particularly among travelers, post-surgical patients, and those with sedentary lifestyles — has driven interest in nattokinase as a preventive supplement. While not a replacement for pharmaceutical anticoagulants, nattokinase's fibrinolytic activity provides a complementary natural approach to maintaining healthy venous circulation. Research in Journal of Cardiovascular Pharmacology supports its role in reducing thrombosis risk factors.

5. Cognitive Health Connection

Emerging research links cardiovascular health to cognitive function — what's good for the heart is good for the brain. By supporting healthy cerebral blood flow and reducing micro-clot formation, nattokinase may contribute to cognitive maintenance. Preclinical studies suggest nattokinase can cross-compensate for impaired fibrinolysis in aging populations, potentially reducing the risk of vascular cognitive impairment (Journal of the American Geriatrics Society, 2021).


Part 3: Wide-Ranging Application Fields

Dietary Supplements & Nutraceuticals

  • Cardiovascular health capsules — Stand-alone nattokinase products targeting the $15B+ heart health supplement market

  • Comprehensive heart formulas — Combined with CoQ10, omega-3, garlic extract, and hawthorn for multi-target cardiovascular support

  • Circulation support blends — Paired with ginkgo biloba, horse chestnut, and Diosmin for venous and arterial health

  • Blood pressure support — Combined with Hawthorn Extract, celery seed, and L-arginine for comprehensive BP management formulas

  • Travel wellness kits — Single-serve nattokinase for long-haul travelers concerned about DVT risk

Functional Foods & Beverages

  • Heart-health fortified foods — Encapsulated nattokinase for functional food applications (requires enteric protection)

  • Wellness beverages — Emerging category of cardiovascular-support functional drinks

Cosmetics & Personal Care

  • Anti-aging topical formulations — Nattokinase's fibrinolytic activity has been explored for topical applications targeting microcirculation and skin firmness

  • Scalp health products — Improved microcirculation supports healthy hair follicle function

Clinical & Research Applications

  • Adjunct cardiovascular research — Being studied as a complementary agent alongside conventional cardiovascular therapies

  • Sports recovery — Nattokinase's fibrinolytic and anti-inflammatory properties are being explored for exercise-induced micro-trauma recovery

  • Veterinary applications — Cardiovascular support in companion animal health products


Part 4: Key Factors in Choosing High-Quality Nattokinase

1. Activity Verification (FU Standard)

Nattokinase potency is measured in Fibrinolytic Units (FU) using the fibrin plate method — the globally recognized standard. Be wary of suppliers quoting potency in non-standard units. Every COA should clearly state activity in FU/g, verified by the fibrin plate assay. Independent laboratory verification (e.g., by JNKA — Japan Nattokinase Association) provides additional confidence.

2. Fermentation Quality Control

Nattokinase is produced through controlled fermentation of soybeans using specific Bacillus subtilis natto strains. Key quality factors include:

  • Strain selection — Only specific natto-producing strains yield the desired subtilisin NAT enzyme

  • Fermentation conditions — Temperature, humidity, and time must be precisely controlled for consistent activity

  • Post-fermentation processing — Lyophilization (freeze-drying) preserves enzyme activity better than heat-based drying

3. Heat Stability vs. Stomach Acid Sensitivity

While nattokinase is relatively heat-stable (active up to 50°C), it is susceptible to degradation by stomach acid (pH 1.5–3.5). This is why enteric-coated capsules are the preferred delivery format for maximum bioavailability. If your product is a standard capsule, ensure your formulation accounts for partial gastric degradation when calculating effective dosage.

4. Soy Allergen Considerations

Nattokinase is derived from fermented soybeans and contains soy proteins. This must be clearly disclosed on product labels for markets with allergen labeling requirements (US FDA, EU FIC, Australia/New Zealand). For soy-free formulations, research-grade non-soy nattokinase alternatives exist but are significantly more expensive and less commercially established.

5. Regulatory Status

Nattokinase has achieved important regulatory milestones:

  • Japan — Approved as a Food for Specified Health Use (FOSHU) for blood pressure claims

  • United States — GRAS status; marketed as a dietary supplement ingredient

  • Canada — Approved as a Natural Health Ingredient (NHI)

  • European Union — Status varies by member state; consult local regulations before market entry

  • China — Approved as a new food ingredient (新食品原料)


Part 5: Why Choose Us as Your Nattokinase Partner

As an experienced botanical and enzyme ingredient supplier, we provide nattokinase products backed by rigorous quality standards and technical expertise:

  • Verified activity guarantees — Every batch tested by fibrin plate method, with FU activity clearly stated and guaranteed on the COA

  • Complete potency range — From 20,000 to 100,000+ FU/g, plus enteric-coated granules for optimized gastric delivery

  • GMP-certified production — ISO 22000, HACCP, Kosher, and Halal certified fermentation and processing facilities

  • Comprehensive documentation — COA (with FU activity verification), MSDS, TSE/BSE-free statement, allergen declaration, non-GMO certificate, and heavy metal/pesticide/microbiological reports — all provided with every shipment

  • Custom formulation support — Our technical team assists with dosage optimization, delivery format selection (standard vs. enteric-coated), and stability testing for your specific product format

  • Regulatory documentation packages — Pre-prepared regulatory support files for US, Japan, Canada, and Southeast Asian markets; customized documentation available for EU and other regions

  • Competitive pricing with stable supply — Direct fermentation capabilities and scale production ensure consistent quality and cost-competitive pricing across all potency levels

  • Technical consultation — Dedicated application scientists available for formulation guidance, stability studies, and clinical trial design support


Conclusion & Call to Action

Nattokinase stands as one of the most scientifically validated natural ingredients for cardiovascular health support. Its unique direct fibrinolytic mechanism, combined with growing clinical evidence for blood pressure support, circulatory health, and atherosclerosis prevention, makes it an essential component of any comprehensive heart-health product portfolio.

With global cardiovascular health supplement demand growing at 6–8% annually and nattokinase awareness accelerating in Western markets, there has never been a better time to introduce or expand nattokinase-based products.

Interested in Nattokinase? Contact us today for:

  • Current pricing and volume-based discounts

  • Free evaluation samples (standard 5–10g)

  • Custom potency specifications and enteric-coated options

  • Complete technical documentation and regulatory support packages

Our nattokinase specialists are ready to provide expert technical consultation, formulation support, and customized solutions to help you develop market-leading cardiovascular health products.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. All product claims should be reviewed for compliance with applicable regulations in your target market before use in commercial products. Nattokinase is not intended to replace prescribed medications. Consult a healthcare professional before use.



Hey there! Your message matters! It'll go straight into our CRM system. Expect a one-on-one reply from our CS within 7×24 hours. We value your feedback. Fill in the box and share your thoughts!
Get a Quote